Iavazzo Christos, Vorgias George, Iavazzo Paraskevi Evangelia, Gkegkes Ioannis D
Department of Gynecological Oncology, Christie Hospital, Manchester, United Kingdom.
Department of Gynecological Oncology, Metaxa Cancer Hospital, Piraeus, Greece.
J Turk Ger Gynecol Assoc. 2017 Mar 15;18(1):43-47. doi: 10.4274/jtgga.2016.0090.
Immature teratomas are quite rare tumors arising in young women. They are usually diagnosed in early stage and grade and have a good prognosis. In these young patients, fertility-sparing management is suggested as the standard of care. Bilateral immature teratoma is a rare condition with an incidence of 10%, with a five-year survival rate of 80%. The majority of patients received fertility-sparing treatment followed by adjuvant chemotherapy in 78%. Older age, advanced stage, and high grade are negative prognostic factors. The surgery-only, watch-and-wait approach was evaluated; however, after a median follow-up time of 42 months, 50% of patients experienced recurrence, but they were successfully salvaged with chemotherapy. In a retrospective study, 12 out of 27 patients tried to conceive, resulting in 10 pregnancies (8 after chemotherapy). We present a narrative review of the current literature regarding the essential multidisciplinary approach of such patients in order to achieve the best oncologic and fertility-sparing outcome.
未成熟畸胎瘤是年轻女性中较为罕见的肿瘤。它们通常在早期被诊断出来,分级较低,预后良好。对于这些年轻患者,建议保留生育功能的治疗作为标准治疗方案。双侧未成熟畸胎瘤是一种罕见情况,发生率为10%,五年生存率为80%。大多数患者接受了保留生育功能的治疗,78%的患者随后接受了辅助化疗。年龄较大、分期较晚和分级较高是不良预后因素。对单纯手术、观察等待的方法进行了评估;然而,在中位随访时间42个月后,50%的患者出现复发,但通过化疗成功挽救。在一项回顾性研究中,27名患者中有12名尝试怀孕,共怀孕10次(化疗后8次)。我们对当前文献进行叙述性综述,探讨对此类患者采取必要的多学科方法,以实现最佳的肿瘤学和保留生育功能的结果。